361 Results (Page 14 of 15)
Saudi Arabia Markets Research Reports
Saudi Arabia Hypersomnia Therapeutics Market Analysis
The Saudi Arabia Hypersomnia Therapeutics Market was valued at $184.89 Mn in 2023 and is predicted to grow at a CAGR of 6.0% from 2023 to 2030, to $278.01 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Pfizer, Sanofi, Teva, GSK, and Novartis among others.
Saudi Arabia Chronic Cough Therapeutics Market Analysis
Saudi Arabia Chronic Cough Therapeutics Market was valued at $107 Mn in 2022 and is estimated to reach $223 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The primary factor fuelling the expansion of the chronic cough therapeutics market is the widespread occurrence of chronic respiratory infections, as the presence of such conditions is frequently indicated by chronic cough. Currently, major players in this market include GlaxoSmithKline (GSK), Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Procter & Gamble (P&G), Reckitt Benckiser Group, Perrigo Company, Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc., and Jamieson Laboratories.
Saudi Arabia Dental Implant Market Analysis
Saudi Arabia Dental Implant Market was valued at $84.80 Mn in 2023 and is predicted to grow at a CAGR of 11.3% from 2023 to 2030, to $179.50 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, medical tourism potential, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Saudi Arabia PET Scan Market Analysis
The Saudi Arabia PET Scan Market was valued at $33 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $52.6 Mn by 2030. The key drivers of the market include increased healthcare expenditure, increased geriatric population, and rising prevalence of chronic diseases. The prominent players of the Saudi Arabia PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
Saudi Arabia Genomic Diagnostics Market Analysis
Saudi Arabia Genomic Diagnostics Market was valued at $555.05 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $1,768.10 Mn by 2030. The key drivers of this industry include increasing prevalence, government initiatives, and personalized medicine. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Saudi Arabia Mouth Ulcer Therapeutics Market Analysis
The Saudi Arabia Mouth Ulcer Therapeutics Market was valued at $25.8 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $37.3 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players Pfizer, Teva Pharmaceuticals, GlaxoSmithKline PLC, Riyadh Pharma, Hikma Pharmaceuticals among others.
Saudi Arabia Ear Infection Therapeutics Market Analysis
Saudi Arabia Ear Infection Therapeutics Market valued at $201 Mn in 2022, is projected to reach $337 Mn by 2030 with a 6.7% CAGR. The rising prevalence of ear infections, particularly in children, is a key driver for the growth of the ear infection therapeutics market, as the increased incidence fosters a demand for effective solutions, propelling research, development, and market availability of treatments to address this widespread medical condition. Key players in this industry include Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck Sharp & Dohme, Eli Lilly, Novartis, Hikma Pharmaceuticals, Meda Pharmaceuticals, Saudi Pharmaceutical Industries, and Nahdi Medical Company.
Saudi Arabia Compression Therapy Market Analysis
Saudi Arabia Compression Therapy Market was valued at $65 Mn in 2022 and is estimated to reach $112 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The increasing occurrence of venous conditions such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Medi France, Sigvaris, Juzo, Bauerfeind, Jobst, Lympha Press, FLA Orthopedics, Al-Johaifa Medical, Nahdi Pharmacy, and AstraZeneca.
Saudi Arabia CT Scan Market Analysis
Saudi Arabia CT Scan Market was valued at $78.37 Mn in 2023 and is predicted to grow at a CAGR of 9.37% from 2023 to 2030, to $146.7 Mn by 2030. The key drivers of this industry include the aging population, increasing cancer rates, and technological advancement. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Saudi Arabia Mental Health Apps Market Analysis
The Saudi Arabia Mental Health Apps Market was valued at $105.4 Mn in 2023 and is predicted to grow at a CAGR of 16.7% from 2023 to 2030, to $310.7 Mn by 2030. The key drivers of this industry include reduced stigma, increasing smartphone penetration, and a shortage of professionals. The industry is primarily dominated by players such as Labayh, Tuhoon, Qareboon, and Psychological Health among others.
Saudi Arabia Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The Saudi Arabia Cough Hypersensitivity Syndrome Therapeutics Market was valued at $138 Mn in 2022 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $244 Mn by 2030. The key drivers of this industry include the surge in prevalence of Cough Hypersensitivity Syndrome, supportive government initiatives, and the emergence of novel therapeutics. The industry is primarily dominated by players such as Sanofi, Pfizer, Almirall, Novartis, Johnson & Johnson, and GSK among others.
Saudi Arabia Bio-Implant Market Analysis
The Saudi Arabia Bio-implant Market was valued at $1105 Mn in 2023 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to $1821.3 Mn by 2030. The Saudi Arabia Bio-implant Market is growing due to Rising Medical Tourism, Growing Awareness and Acceptance, and Government Healthcare Initiatives. The market is primarily dominated by players such as Cochlear Ltd. Edwards Lifesciences Corporation, Berlin Heart, Medtronic, Jarvik Heart Inc., Abiomed, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Saudi Arabia Herbal Supplements Market Report
The Saudi Arabia Herbal Supplements Market was valued at $89.42 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $150.30 Mn by 2030. The key drivers of this industry include health consciousness, preventive healthcare trends, and the young population. The industry is primarily dominated by players such as Himalaya Wellness, NOW Foods, Botanic Supplements, and Dabur among others.
Saudi Arabia Actinic Keratosis Therapeutic Market Analysis
The Saudi Arabia Actinic Keratosis Therapeutic Market is expected to witness substantial growth, with an estimated increase from $116 Mn in 2022 to $190 Mn by 2030 and a forecasted CAGR projected to be 6.4%. This expected growth is attributed to the intersection of certain factors such as the sun-exposed demographics in Saudi Arabia, increased public awareness of Actinic Keratosis and the ways of treating it, and a growing array of treatment options, including advanced technological solutions and minimally invasive procedures. Key players in the Saudi Arabia Actinic Keratosis Therapeutics Market include Bayer, Galderma, LEO Pharma, Sun Pharmaceuticals, Syneron Candela, Lumenis, Zimmer Biomet, among others
Saudi Arabia Brugada Syndrome Market Analysis
The Saudi Arabia Brugada Syndrome Market was valued at $20.4 Mn in 2023 and is predicted to grow at a CAGR of 9.3% from 2023 to 2030, to $38 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the Saudi Arabia Brugada Syndrome Market are Jamjoom Pharma, Baxter, Riyadh Pharma, Sanofi, Novartis, and AstraZeneca, among others.
Saudi Arabia Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Saudi Arabia Clinical Nutrition for Chronic Kidney Diseases Market was valued at $26.70 Mn in 2023 and is predicted to grow at a CAGR of 7.53% from 2023 to 2030, to $44.40 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Saudi Arabia Brain Cancer Therapeutics Market
Saudi Arabia Brain Cancer Therapeutics Market valued at $39 Mn in 2022, projected to reach $98 Mn by 2030 with a 12.1% CAGR. The market for brain cancer therapeutics is expected to be driven by the anticipated rise in the incidence of brain cancer, especially glioblastoma multiforme, which would raise the demand for therapeutics. The leading pharmaceutical companies presently operating in the industry are Roche, Merck, Novartis, Bristol Myers Squibb, Eli Lilly, Pfizer, AstraZeneca, Teva Pharmaceutical Industries, Sanofi, and Ipsen.
Saudi Arabia Dental Endodontics Market Analysis
Saudi Arabia Dental Endodontics Market was valued at $29.80 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $44.10 Mn by 2030. The key drivers of this industry include a growing focus on oral health, the rising prevalence of dental problems, government vision and initiatives, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, 3M Company, and ZimVie Inc. among others.
Saudi Arabia Blood Disorder Therapeutics Market
Saudi Arabia Blood Disorder Therapeutics Market valued at $228 Mn in 2022, projected to reach $454 Mn by 2030 with a 9% CAGR. Several factors are converging to cause market expansion, such as a young and expanding population, government initiatives supporting improved healthcare accessibility, advocacy groups raising awareness about advanced therapies, and digital healthcare integration. The Saudi Arabia Blood Disorder Therapeutics Market encompasses various players across different segments, including Pfizer, Roche, Takeda Pharmaceuticals, Novartis, Sanofi, Novo Nordisk, Bayer, Jamjoom Pharma, Tabuk Pharma, Tamer Pharma etc, among various others.
Saudi Arabia Clinical Nutrition Market Analysis
The Saudi Arabia Clinical Nutrition Market was valued at $521.4 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $828.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Almarai, Tabuk Pharmaceuticals, Abbott Nutrition, Pfizer Inc, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among other.
Saudi Arabia Breast Pump Market Report
The Saudi Arabia Breast Pump Market was valued at $50 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $98 Mn by 2030. The key drivers of the market include the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the Saudi Arabia Breast Pump Market are Microlife, Nubeca, Nuby, Bistos, Ameda, Avent, Evenflo, Pigeon, Playtex, and Horigen.
Saudi Arabia Cancer Induced Bone Disease Therapeutics Market
Saudi Arabia Cancer Induced Bone Disease Therapeutics Market valued at $22 Mn in 2022, projected to reach $39 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the rising incidence of cancer, the expanding therapeutic landscape, supportive government initiatives, and others. The industry is primarily dominated by players such as Amgen, Julphar, Novartis, Janssen, Sanofi, Roche, and Celgene among others.
Saudi Arabia Digital Biomarkers Market Analysis
Saudi Arabia Digital Biomarkers Market was valued at $49.30 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $219.73 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Saudi Arabia Medication Access Programs Market Analysis
The Saudi Arabia Medication Access Programs Market was valued at $93.3 Mn in 2023 and is predicted to grow at a CAGR of 16.1% from 2023 to 2030, to $265.3 Mn by 2030. The key drivers of this industry include increasing chronic disease burden, government initiatives, and pharmaceutical innovation. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
Saudi Arabia Congestive Heart Failure Therapeutics Market Analysis
The Saudi Arabia Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $175 Mn in 2022 to $308 Mn by 2030, with a CAGR of 7.3% during the forecast period of 2022-2030. The market is propelled due to the confluence of certain factors like the rapidly increasing prevalence of CHF among the population, the increase in research leading to advances in medical technologies that provide more treatment options, and the increase in public awareness about the risk factors and the disease. The Saudi Arabia Congestive Heart Failure Therapeutics Market has various key players across different therapeutic segments, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, AstraZeneca, Tabuk Pharmaceuticals, Riyadh Pharma, Avalon Pharma, Jamjoom Pharma, etc, among various others.